A detailed history of Radnor Capital Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Radnor Capital Management, LLC holds 44,513 shares of OGN stock, worth $804,349. This represents 0.13% of its overall portfolio holdings.

Number of Shares
44,513
Previous 44,563 0.11%
Holding current value
$804,349
Previous $922,000 7.59%
% of portfolio
0.13%
Previous 0.28%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$18.65 - $23.03 $932 - $1,151
-50 Reduced 0.11%
44,513 $852,000
Q2 2024

Jul 12, 2024

SELL
$17.45 - $21.96 $17,833 - $22,443
-1,022 Reduced 2.24%
44,563 $922,000
Q1 2024

Apr 11, 2024

SELL
$13.78 - $18.8 $8,777 - $11,975
-637 Reduced 1.38%
45,585 $857,000
Q4 2023

Jan 11, 2024

SELL
$10.95 - $17.32 $69,094 - $109,289
-6,310 Reduced 12.01%
46,222 $667,000
Q3 2023

Oct 12, 2023

SELL
$16.59 - $23.77 $39,699 - $56,881
-2,393 Reduced 4.36%
52,532 $912,000
Q2 2023

Jul 07, 2023

SELL
$19.27 - $24.63 $2,389 - $3,054
-124 Reduced 0.23%
54,925 $1.14 Million
Q1 2023

Apr 06, 2023

SELL
$21.42 - $32.08 $102,430 - $153,406
-4,782 Reduced 7.99%
55,049 $1.3 Million
Q4 2022

Jan 09, 2023

SELL
$23.31 - $28.61 $20,699 - $25,405
-888 Reduced 1.46%
59,831 $1.69 Million
Q3 2022

Oct 12, 2022

SELL
$23.4 - $34.25 $1,895 - $2,774
-81 Reduced 0.13%
60,719 $1.42 Million
Q2 2022

Jul 11, 2022

SELL
$31.66 - $38.9 $24,251 - $29,797
-766 Reduced 1.24%
60,800 $2.05 Million
Q1 2022

Apr 25, 2022

BUY
$30.45 - $39.36 $9,561 - $12,359
314 Added 0.51%
61,566 $2.15 Million
Q4 2021

Jan 20, 2022

SELL
$28.67 - $37.13 $97,793 - $126,650
-3,411 Reduced 5.28%
61,252 $1.87 Million
Q3 2021

Oct 26, 2021

BUY
$28.63 - $35.64 $88,638 - $110,341
3,096 Added 5.03%
64,663 $2.12 Million
Q2 2021

Jul 21, 2021

BUY
$28.45 - $38.0 $1.75 Million - $2.34 Million
61,567 New
61,567 $1.86 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.6B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.